Funded Tech Companies
Zafgen
Researching who backed Zafgen? Oxford Finance, MidCap Financial and Brookside Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Zafgen
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
175 Portland St. 4th Floor
Boston, MA 02114
USA
Boston, MA 02114
USA
Phone
Website
Email Address
Company Background Information
Overview
Zafgen (NASDAQ: ZFGN) is developing beloranib, a novel obesity therapy that demonstrates a unique mechanism of action, re-establishing balance to the ways the body produces and uses fat stored in adipose tissue.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/19/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Hatfield
Chief Financial Officer
Patricia Allen
Chief Medical Officer
Dennis Kim
VP - Bus. Development
Brian McVeigh
VP - Bus. Development
James Vath
Company Investors
- Oxford Finance (Christopher Herr)
- MidCap Financial
- Brookside Capital
- Venrock
- RA Capital
- Alta Partners (Ed Hurwitz)
- Third Rock Ventures (Kevin Starr)
- Atlas Venture (Peter Barrett)
- Third Rock Ventures (Lou Tartaglia)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs